Skip to main content

Patient Centricity

At Boehringer Ingelheim, we put patients first in everything we do. Patients inspire us in our mission to lead the science that creates breakthrough therapies. Our goal is to serve people through research into diseases with unmet needs and the provision of new therapies and healthcare solutions to transform the lives of patients. As an independent and family-owned company, we have the freedom to pursue our long-term vision, to make transformative therapies for life-enhancing healthcare improvements.

Links to other sections from Patient Centricity

Mutual benefit: Patient centricity in clinical trials

Mutual benefit: Patient centricity in clinical trials

Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.

Read more
Rare Diseases: Rare but not alone
Patient Centricity

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.
Read more
Patient Centricity

Our position

Boehringer Ingelheim’s position on compassionate use of investigational medications.
Read more

Related Content

Read more
Carinne in conversation with two rare disease experts, talking about the importance of treatment options and awareness of rare diseases.
GPP

“Rare diseases are quite common”

Individually, they may be rare. All together they affect millions.
Read more